Tech Company Financing Transactions
Singulex Funding Round
Singulex, based in Alameda, secured $15.3 million from Fisk Ventures, OrbiMed and Prolog Ventures.
Transaction Overview
Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$15,336,000
Round
Undisclosed
Investors
Fisk Ventures (Stephen Rose)
OrbiMed (Carl Gordon)
Prolog Ventures (Gregory Johnson)
Rally Ventures (Hironori Hozoji)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1701 Harbor Bay Pkwy. 200
Alameda, CA 94502
USA
Alameda, CA 94502
USA
Phone
Website
Email Address
Overview
Singulex is an early stage biotechnology company with research and development laboratories in St. Louis and commercial operations in Hayward, California.Singulex has obtained exclusive license to all intellectual property around its core technology and has further fortified this position.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guido Baechler
Chief Scientific Officer
John Todd
VP - Bus. Development
Thomas Schlumpberger
VP - Finance
Brandon Hants
VP - Human Resources
Byron Clendenen
VP - Marketing
Jessica McCarthy
VP - Operations
Mark Stene
VP - R & D
Jeffrey Bishop
VP - Regulatory Affairs
Karen Richards
VP - Sales
Robert Brousseau
Browse more venture capital transactions:
Prev: 3/31/2012: 3dna venture capital transaction
Next: 3/31/2012: SocialWire venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs